Sanofi Recalls Elitek (Rasburicase) Vials Due to Stability Testing Failures
Sanofi-Aventis is recalling 7,451 vials of Elitek (rasburicase) because routine stability testing showed enzyme activity levels were out of specification.
- Product
- ELITEK — ELITEK (RASBURICASE)
- Category
- Drug
- Distribution
- Distributed nationwide